欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0918/001
药品名称
Numeta G13E
活性成分
alanine 4.66 g
glucose monohydrate 550.0 g
glycine 2.33 g
histidine 2.21 g
isoleucine 3.9 g
soybean oil 0.0 g
threonine 2.16 g
tryptophan 1.17 g
taurine 0.35 g
sodium glycerophosphate 6.15 g
serine 2.33 g
proline 1.75 g
potassium acetate 3.83 g
phenylalanine 2.45 g
ornithine hydrochloride 1.85 g
olive oil 0.0 g
methionine 1.4 g
magnesium acetate 1.68 g
lysine monohydrate 7.2 g
leucine 5.83 g
glutamic acid 5.83 g
cysteine 1.1 g
calcium chloride 3.45 g
aspartic acid 3.5 g
arginine 4.89 g
valine 4.43 g
tyrosine 0.45 g
剂型
Emulsion for infusion
上市许可持有人
Baxter Medical AB Sweden
参考成员国 - 产品名称
Sweden (SE)
Numeta G19E
互认成员国 - 产品名称
France (FR)
Portugal (PT)
Greece (GR)
Norway (NO)
Poland (PL)
Belgium (BE)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
许可日期
2010/12/15
最近更新日期
2024/05/28
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Fixed combination Art 10b Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0918_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0918_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0918_001_PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase